Wordt geladen...
Far-red Light-activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-specific Paclitaxel Chemotherapy
Paclitaxel (PTX) is one of the most useful chemotherapeutic agents approved for several cancers, including ovarian, breast, pancreatic, and non-small cell lung cancer. However, it causes systemic side effects when administered parenterally. Photodynamic therapy (PDT) is a new strategy for treating l...
Bewaard in:
| Gepubliceerd in: | J Med Chem |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5080911/ https://ncbi.nlm.nih.gov/pubmed/26974508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jmedchem.5b01971 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|